Monday September 14, 2026
Section

Local

European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
Press Release

European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP

Today's GeNeuro patent milestone adds a potentially significant ALS opportunity to an already expanding NRx platform,

Read Full Story